December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Leukocyte Trafficking in Experimental Autoimmune Uveitis: Breakdown of Blood-retinal-barrier and Up-regulation of Cellular Adhesion Molecules
Author Affiliations & Notes
  • H Xu
    Ophthalmology Aberdeen University Medical School Aberdeen United Kingdom
  • JV Forrester
    Ophthalmology Aberdeen University Medical School Aberdeen United Kingdom
  • J Liversidge
    Ophthalmology Aberdeen University Medical School Aberdeen United Kingdom
  • IJ Crane
    Ophthalmology Aberdeen University Medical School Aberdeen United Kingdom
  • Footnotes
    Commercial Relationships   H. Xu, None; J.V. Forrester, None; J. Liversidge, None; I.J. Crane, None. Grant Identification: The Wellcome Trust Grant 057311
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1565. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H Xu, JV Forrester, J Liversidge, IJ Crane; Leukocyte Trafficking in Experimental Autoimmune Uveitis: Breakdown of Blood-retinal-barrier and Up-regulation of Cellular Adhesion Molecules . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1565.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To clarify the order of events occurring in the breakdown of the blood-retina barrier (BRB) in experimental autoimmune uveitis (EAU) and to study the relationships between increased vascular permeability, up-regulation of endothelial cell adhesion molecules, and leukocyte adhesion and infiltration during EAU. Methods: B10.RIII mice were immunized with human IRBP peptide 161-180. Changes in the retinal vasculature were examined at different days post-immunization (pi). Evans blue was administered intravenously to assess vascular permeability. Expression of adhesion molecules ICAM-1, VCAM-1, P-selectin, E-selectin, and PECAM-1 were evaluated by in vivo antibody administration. Lymphocytes from inguinal lymph nodes of normal and peptide-immunized mice were labelled in vitro with calcein-AM, infused intravenously into similarly treated syngeneic mice. Retinal flat mounts were observed 24 hours later by confocal microscopy to determine lymphocyte adhesion and infiltration. Results: The first observation of an increase in vascular permeability occurred at day 7 pi and was restricted to focal areas of the retinal venules of the inner vascular plexus. This progressively extended to the outer vascular plexus at day 9 pi. Specific adhesion of leukocytes to the endothelium of retinal venules was first observed at day 6 pi. Leukocyte extravasation into the retinal parenchyma from these vessels began at day 8 pi and extended to the outer vascular plexus at day 9 pi. The expression of adhesion molecules increased progressively during the development of EAU. ICAM-1, P-selectin and E-selectin were expressed predominately in retinal venules, the sites of BRB breakdown, cell adhesion and extravasation. The increase in ICAM-1 and P-selectin expression was associated both spatially and temporally with BRB breakdown, cell adhesion and extravasation. No increase in expression of P-selectin and ICAM-1 was observed either in the mesenteric vessels of EAU mice or in the retinal vessels of ovalbumin immunized mice. Conclusion: The sequence of event in EAU appears to be focal adhesion of leukocytes to discrete sites on retinal venules, followed by upregulation of adhesion molecules especially ICAM-1, P-selectin and breakdown of the BRB, leading to transmigration of leukocytes and recruitment of large numbers of cells to the retinal parenchyma. These changes occur over a short period of 6-9 days pi and initiate the process of tissue damage during the following 2-3 weeks.

Keywords: 612 uveitis-clinical/animal model • 327 autoimmune disease • 339 cell adhesions/cell junctions 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×